Alex

Silvercrest Asset Management Group Inc. Announces $12 Million Common Stock Repurchase Program

NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG)…

Stronghold Reports Second Quarter 2024 Operating and Financial Results

Continues Formal Review of Strategic Alternatives Pursuing Significant Site Expansion and Evaluating GPU Computing Potential…

Track Group Reports 3rd Quarter Fiscal 2024 Financial Results

NAPERVILLE, Ill., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK), a global…

GAMCO Investors, Inc. Reports Results for the 2nd Quarter 2024

Quarter End AUM of $30.7 billion; Average AUM of $31.1 billion for the Second Quarter…

Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - The demand…

YY Group Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

SINGAPORE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”,…

Asure Announces Second Quarter 2024 Results

Reports Second Quarter Revenues of $28 Million Recurring Revenues Grew 18% Versus Prior Year Second…

Asure Announces Second Quarter 2024 Results

Reports Second Quarter Revenues of $28 Million Recurring Revenues Grew 18% Versus Prior Year Second…

Silvercrest Asset Management Group Inc. Reports Q2 2024 Results

NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG)…

BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA)

“Monovalent recombinant acellular pertussis vaccine proven to significantly boost immunity against pertussis” LYON, France--(BUSINESS WIRE)--BioNet…